Nargiz Noimann, Founder of X-Technology
Clinicians rightly celebrate when treatment ends. Yet many patients leave our clinics still carrying the invisible weight of illness—anxiety, low mood, pain, and a fragile sense of self. The evidence…
Continue Reading
Recent advances in artificial intelligence, particularly large language models (LLMs), show promise for mental health applications, including the automated detection of depressive symptoms from natural language. We fine-tuned a German BERT-based LLM to predict…
Continue Reading
Jeanne Marconi, MD, SVP for Business Development and Strategic Partnerships at Brightline
We’re facing a pediatric mental health crisis that’s worsening by the day. Amid a national provider shortage, increased rates of anxiety, depression, and…
Continue Reading
Multimodal smartphone sensor data provide rich insights into real-world behavioural patterns associated with anxiety and depression symptoms. We propose that variability in daily routines across life aspects may act as a personalised digital marker,…
Continue Reading
Preventing mental disorders is important to avoiding clinical conditions. This study evaluated the efficacy of internet-based indicated prevention for anxiety and depressive disorders. In a three-arm randomized controlled trial, 566 adults with subthreshold anxiety…
Continue Reading
Patients with diabetes are at increased risk of comorbid depression or anxiety, complicating their management. This study evaluated the performance of large language models (LLMs) in detecting these symptoms from secure patient messages. We…
Continue Reading
Dr Cynthia Bullock, director, healthy lives at Innovate UK (Credit: Cynthia Bullock)
More than £3.6 million has been awarded to 17 extended reality (XR) projects to create immersive digital mental health therapeutics to tackle…
Continue Reading
Background: Mental health concerns are prevalent among university students, with financial stress further compounding these issues. While cognitive-behavioral therapy (CBT) is effective for these conditions, its delivery through artificial intelligence (AI) chatbots represents a…
Continue Reading
Personalising psychotherapies for depression may enhance their efficacy. We conducted a randomised controlled trial of smartphone cognitive-behavioural therapy (CBT) among 4,469 adults in Japan (RESiLIENT trial, UMIN-CTR UMIN000047124). Participants received one of nine CBT…
Continue Reading
Depression is a prevalent and costly mental disorder across all ages. Artificial intelligence (AI)-assisted physiological and behavioral information—such as electroencephalography (EEG), eye movement, video or audio monitoring, and gait analysis—offers a promising tool for…
Continue Reading
